A detailed history of Squarepoint Ops LLC transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 53,039 shares of RCKT stock, worth $606,235. This represents 0.0% of its overall portfolio holdings.

Number of Shares
53,039
Holding current value
$606,235
% of portfolio
0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$17.6 - $25.88 $933,486 - $1.37 Million
53,039 New
53,039 $979,000
Q1 2024

May 15, 2024

BUY
$26.16 - $30.74 $20,117 - $23,639
769 Added 2.91%
27,229 $733,000
Q4 2023

Feb 14, 2024

BUY
$16.78 - $31.94 $166,105 - $316,174
9,899 Added 59.77%
26,460 $793,000
Q2 2023

Aug 14, 2023

BUY
$16.59 - $23.6 $274,746 - $390,839
16,561 New
16,561 $329,000
Q4 2022

Feb 14, 2023

SELL
$15.5 - $22.76 $180,947 - $265,700
-11,674 Reduced 48.9%
12,201 $238,000
Q3 2022

Nov 14, 2022

BUY
$12.37 - $18.41 $295,333 - $439,538
23,875 New
23,875 $381,000
Q2 2022

Aug 15, 2022

SELL
$7.96 - $16.64 $223,325 - $466,851
-28,056 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$13.16 - $23.68 $180,489 - $324,771
-13,715 Reduced 32.83%
28,056 $445,000
Q4 2021

Feb 14, 2022

BUY
$21.52 - $36.02 $898,911 - $1.5 Million
41,771 New
41,771 $912,000
Q2 2021

Aug 16, 2021

SELL
$39.41 - $47.25 $745,755 - $894,111
-18,923 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$43.34 - $65.91 $90,450 - $137,554
-2,087 Reduced 9.93%
18,923 $840,000
Q4 2020

Feb 16, 2021

SELL
$23.3 - $59.57 $276,757 - $707,572
-11,878 Reduced 36.12%
21,010 $1.15 Million
Q3 2020

Nov 16, 2020

SELL
$20.5 - $28.59 $508,953 - $709,803
-24,827 Reduced 43.02%
32,888 $752,000
Q2 2020

Aug 14, 2020

BUY
$13.32 - $22.61 $768,763 - $1.3 Million
57,715 New
57,715 $1.21 Million
Q1 2020

May 15, 2020

SELL
$9.71 - $25.11 $187,034 - $483,668
-19,262 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$11.07 - $24.23 $169,548 - $371,106
-15,316 Reduced 44.29%
19,262 $438,000
Q3 2019

Nov 14, 2019

SELL
$10.85 - $14.78 $46,503 - $63,347
-4,286 Reduced 11.03%
34,578 $403,000
Q2 2019

Aug 14, 2019

BUY
$15.0 - $19.81 $75,120 - $99,208
5,008 Added 14.79%
38,864 $583,000
Q1 2019

May 15, 2019

SELL
$13.45 - $19.01 $182,422 - $257,832
-13,563 Reduced 28.6%
33,856 $594,000
Q4 2018

Feb 14, 2019

BUY
$11.21 - $23.53 $406,014 - $852,233
36,219 Added 323.38%
47,419 $703,000
Q3 2018

Nov 14, 2018

BUY
$18.5 - $25.49 $207,200 - $285,488
11,200 New
11,200 $276,000

Others Institutions Holding RCKT

About ROCKET PHARMACEUTICALS, INC.


  • Ticker RCKT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 75,683,696
  • Market Cap $865M
  • Description
  • Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...
More about RCKT
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.